Prolonged hemophagocytic lymphohistiocytosis syndrome as an initial presentation of Hodgkin lymphoma: a case report
© Chan et al; licensee BioMed Central Ltd. 2008
Received: 03 March 2008
Accepted: 04 December 2008
Published: 04 December 2008
Hemophagocytic lymphohistiocytosis is an immune-mediated syndrome that typically has a rapidly progressive course that can result in pancytopenia, coagulopathy, multi-system organ failure and death.
A 57-year-old Caucasian woman was referred in fulminant hemophagocytic lymphohistiocytosis, with fever, pancytopenia, splenomegaly, mental status changes and respiratory failure. She was found to have stage IV classical Hodgkin lymphoma, in addition to Epstein-Barr virus and cytomegalovirus viremia. Her presentation was preceded by a 3-year prodrome consisting of cytopenia and fever that were partially controlled by steroids and azathioprine.
Fulminant hemophagocytic lymphohistiocytosis may follow a prodromal phase that possesses features suggestive of a chronic form of hemophagocytic lymphohistiocytosis, but which may also resemble immune cytopenias of other causes. A diagnosis of hemophagocytic lymphohistiocytosis should be considered in the setting of chronic pancytopenia.
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome characterized by fever, hepato-splenomegaly, lymphadenopathy, pancytopenia, rash, and hemophagocytosis by non-malignant macrophages [1, 2]. Laboratory findings characteristic of this disease include hypertriglyceridemia, hyperferritinemia, hypofibrinogenemia and liver function test abnormalities. The symptoms of HLH are typically rapidly progressive, often resulting in death from hemorrhage, multi-system organ failure, or infection. Survival from HLH requires prompt recognition of the syndrome, correction of its underlying cause, and HLH-specific therapies such as etoposide .
HLH occurs in both inherited and acquired forms. Inherited forms have been attributed to defects in perforin function and other intracellular pathways required for the release of cytolytic granules by NK cells and cytotoxic T-lymphocytes . In its acquired forms, HLH has been associated with infections, such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV), inflammatory diseases, such as juvenile rheumatoid arthritis, and malignancies, such as T-cell non-Hodgkin lymphoma and Hodgkin lymphoma (HL) [2, 4]. In HLH, an apparent loss of restraint of the function of normal histiocytic cells is correlated with the elaboration of high levels of interferon-γ by activated CD8+ T-cells and TNF-α and IL-6 by activated macrophages .
Acquired forms of the disease typically follow a rapid course. In a series of six cases associated with Epstein-Barr infection, all of the patients died within 3 months of the initial onset of symptoms . In most cases associated with HL, the first symptoms suggestive of HLH preceded death or definitive therapy by only 1 to 2 months [7–11].
A 57-year-old Caucasian woman was admitted to a hospital in Philadelphia, PA, USA in October, 2006 for persistent fever and pancytopenia following debridement of a buttock abscess.
Admission laboratory studies
Iron binding capacity
White blood cell count
2.7 × 109/liter
4–11 × 109/liter
15 × 109/liter
140–400 × 109/liter
Direct antiglobulin test
Eleven days before her referral, she was admitted to an outside hospital with temperature of 38.6°C (101.5°F) and a right buttock abscess. Her WBC was 0.5 × 109/liter, Hb 75 g/liter, platelets 47 × 109/liter. The buttock lesion was debrided. Bone marrow biopsy showed a hypercellular marrow with erythroid and megakaryocytic hyperplasia and clusters of atypical megakaryocytes. Her medications included decadron 20 mg q 12 hours, filgrastim, darbepoietin, albumin, imipenem, diflucan, acyclovir, protonix, folate, and vitamin B12.
Examination was notable for temperature 37.7°C (100.0°F), blood pressure 126/68, respiratory rate 28, pulse 122, oxygen saturation 92% on room air. She had pallor, mild jaundice, a 2/6 systolic flow murmur, splenomegaly, a 3 × 3 cm right buttock eschar, ecchymoses on her arms and left flank, and 3+ bilateral lower extremity edema. She had no lymphadenopathy, hepatomegaly, or musculoskeletal findings. Her mental status exam was significant for a flat affect and orientation to self, but not to the current year, the hospital name, or her date of birth.
Laboratory studies (Table 1) were remarkable for pancytopenia and a coagulopathy. She had elevations in her ferritin, triglycerides, bilirubin, and liver function tests. Her haptoglobin was low, but her direct anti-globulin test was negative. Her peripheral blood smear demonstrated no spherocytic or microangiopathic changes. An antinuclear antibody (ANA) screen was also negative.
Chest CT demonstrated bibasilar patchy pulmonary consolidation, small pleural effusions, and small calcified mediastinal lymph nodes. Abdominal CT scan showed an enlarged spleen with 10 low-density, indeterminate lesions, similar lesions in the liver, bilateral renal infarcts, and a left psoas hemorrhage. Head CT and echocardiography were unremarkable.
Decadron, antibiotics, and growth factors were continued. A diagnosis of hemophagocytic syndrome was considered, and intravenous cyclosporine was started. Despite aggressive transfusion support, minimal changes were noted in her pancytopenia and coagulopathy. Blood cultures were negative for bacterial, fungal, and mycobacterial pathogens. EBV serologies were notable for IgG EBV capsid protein and IgG EBNA antibodies, but negative for IgM EBV capsid antibodies. EBV DNA copy number in the blood was 27,800/ml, and the CMV DNA copy number was 16,500/ml. Tests for human herpesvirus 6 (HHV-6), Hepatitis C, Hepatitis B surface antigen, and human immunodeficiency virus (HIV) were negative.
On the third hospital day, she had increased retroperitoneal bleeding, as indicated by expansion of her flank ecchymosis and an increased red blood cell (RBC) transfusion requirement. She developed respiratory fatigue and required mechanical ventilation. Bronchoscopic examination was unremarkable, but lavage cultures were positive for Stenotrophomonas maltophilia and CMV. Ganciclovir was initiated. She was extubated the following day, but required bilevel positive airway pressure (BiPAP) and continued to have fever and a clouded sensorium.
The bone marrow core biopsy revealed a hypercellular marrow with background maturing trilineage hematopoiesis and a conspicuous increase in large histiocytes/macrophages, many of which contained hemosiderin and/or other hematopoietic elements, consistent with hemophagocytosis. In addition, tumor nodules were present, composed of large, irregular mononuclear cells with scattered, bizarre tumor giant cells containing hyperchromatic nuclei with coarse chromatin and prominent macronucleoli (Figures 1C and 1D). Occasional binucleated Reed-Sternberg (RS) cells were noted (Figure 1E). These tumor nodules occupied approximately 10% to 20% of the total marrow cross-sectional area within the core biopsy and were accompanied by a reticulin fibrosis. The tumor giant cells were strongly positive for CD30 (Figure 1F) and Ki67, but negative for other B-cell and T-cell markers, myeloid markers, CMV antigens and EBV latent membrane protein (LMP). Significant histiocytosis was also noted with phagocytosis of erythroid and myeloid cells (Figure 1G). CD68 staining revealed innumerable histiocytes/macrophages throughout the bone marrow interstitium, many of which contained numerous intact hematopoietic cells (Figure 1H). On the basis of these studies, she received a diagnosis of Stage IV HL with concurrent HLH.
She received a single cycle of dose-reduced adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy for treatment of her HL. Two days later, she had a seizure of 2 to 3 minutes duration that involved her upper extremities and facial muscles. Her bilirubin rose to 316 μmol/liter (18.5 mg/dl), ferritin to 34,820 μg/liter, alanine aminotransferase (ALT) to 265 U/liter, and aspartate aminotransferase (AST) to 388 U/liter. Following a discussion with her health care proxy, comfort measures were instituted and she died the following day.
Post-mortem pathologic studies
In acquired cases of HLH, the clinical course is rapidly progressive with multi-system organ failure often occurring within weeks of the initial diagnosis of the syndrome. In our patient, fulminant HLH was present for approximately 3 weeks before her death. The standard definition of HLH requires that at least 5 of 8 clinical criteria be met: fever, splenomegaly, peripheral cytopenias of 2 or 3 lineages, hypertriglyceridemia, elevated ferritin (>500 μg/liter), elevated soluble CD25 (sCD25), absent NK-cell activity, and histological evidence of HLH in bone marrow, lymph nodes, or spleen. Our patient had six of these: fever, splenomegaly, peripheral cytopenias of three lineages, hypertriglyceridemia, elevated ferritin, and histological evidence of HLH. Typical of HLH, she also had a coagulopathy, liver function test abnormalities, an elevated LDH, and CNS dysfunction.
Non-malignant syndromes that can cause pancytopenia without HLH
Bone marrow failure
Vitamin B12 deficiency
Paroxysmal nocturnal hemoglobinuria
Transfusion-associated graft-versus-host disease
Autoimmune lymphoproliferative syndrome
Systemic lupus erythematosus
If our patient did have chronic HLH, what was the most likely cause? At the time of her death, she had three conditions associated with HLH: active EBV infection, active CMV infection, and HL. Her chronic HLH may have been the result of any of these, but we consider HL to be the most likely cause, since occult HL can exist for many years . In contrast, acute EBV and CMV infections are associated with fever, pharyngitis, lymphadenopathy, and fatigue and would likely have been self-limited. EBV antigens are commonly expressed by RS cells in patients with HL and HLH . In our patient, the RS cells were negative for EBV LMP, indicating that her HL and EBV reactivation were independent disease processes. Treatment with azathioprine and steroids may have facilitated reactivation of EBV and CMV late in her disease course while partially treating her HLH and HL.
We have described a case of acquired HLH that presented in a fulminant form following a 3-year prodrome that was consistent with a mild, chronic form of HLH. Chronic HLH should be considered in the differential diagnosis of fever, splenomegaly and pancytopenia.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
bilevel positive airway pressure
human herpesvirus 6
human immunodeficiency virus
latent membrane protein
mean cell volume
red blood cell
white blood cell count
We thank Bharat K. Asware, M.D. for excellent pulmonary and critical care of the patient. We thank Vincent Dam and Kary Heller for research assistance.
- Favara BE: Hemophagocytic lymphohistiocytosis: a hemophagocytic syndrome. Semin Diagn Pathol. 1992, 9: 63-74.PubMed
- Janka G, Zur Stadt U: Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005, 82-88.
- Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G, Histocyte Society: Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002, 100: 2367-2373. 10.1182/blood-2002-01-0172.View ArticlePubMed
- Fisman DN: Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000, 6: 601-608.PubMed CentralView ArticlePubMed
- Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C: Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood. 2005, 105: 1648-1651. 10.1182/blood-2004-08-2997.View ArticlePubMed
- Kikuta H, Sakiyama Y, Matsumoto S, Oh-Ishi T, Nakano T, Nagashima T, Oka T, Hironaka T, Hirai K: Fatal Epstein-Barr virus-associated hemophagocytic syndrome. Blood. 1993, 82: 3259-3264.PubMed
- Kluin-Nelemans JC, Kluin PM, Bieger R: A 26-year-old man with Hodgkin's disease and rapidly progressive pancytopenia. Ann Hematol. 1993, 67: 49-56. 10.1007/BF01709667.View ArticlePubMed
- Kojima H, Takei N, Mukai Y, Hasegawa Y, Suzukawa K, Nagata M, Noguchi M, Mori N, Nagasawa T: Hemophagocytic syndrome as the primary clinical symptom of Hodgkin's disease. Ann Hematol. 2003, 82: 53-56.PubMed
- Dawson L, den Ottolander GJ, Kluin PM, Leeksma O: Reactive hemophagocytic syndrome as a presenting feature of Hodgkin's disease. Ann Hematol. 2000, 79: 322-326. 10.1007/s002779900130.View ArticlePubMed
- Chim CS, Hui PK: Reactive hemophagocytic syndrome and Hodgkin's disease. Am J Hematol. 1997, 55: 49-50. 10.1002/(SICI)1096-8652(199705)55:1<49::AID-AJH10>3.0.CO;2-1.View ArticlePubMed
- Korman LY, Smith JR, Landaw SA, Davey FR: Hodgkin's disease: intramedullary phagocytosis with pancytopenia. Ann Intern Med. 1979, 91: 60-61.View ArticlePubMed
- Garcia-Carbonero R, Paz-Ares L, Arcediano A, Lahuerta J, Bartolome A, Cortes-Funes H: Favorable prognosis after late relapse of Hodgkin's disease. Cancer. 1998, 83: 560-565. 10.1002/(SICI)1097-0142(19980801)83:3<560::AID-CNCR26>3.0.CO;2-T.View ArticlePubMed
- Menard F, Besson C, Rince P, Lambotte O, Lazure T, Canioni D, Hermine O, Brousset P, Martin A, Gaulard P, Raphaël M, Larroche C: Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. Clin Infect Dis. 2008, 47: 531-534. 10.1086/590152.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.